三元生物
(301206)
| 流通市值：31.14亿 | | | 总市值：48.36亿 |
| 流通股本：1.30亿 | | | 总股本：2.02亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 685,426,109.44 | 257,645,417.58 | 324,985,873.39 | 271,308,584.55 |
| 交易性金融资产 | 621,434,451.05 | 873,945,644.14 | 123,367,116.65 | 366,400,000 |
| 应收票据及应收账款 | 78,344,887.42 | 97,667,087.38 | 85,502,483 | 71,916,806.77 |
| 其中：应收票据 | 1,625,176 | 1,683,993.5 | 1,605,633.7 | 4,056,339.9 |
| 应收账款 | 76,719,711.42 | 95,983,093.88 | 83,896,849.3 | 67,860,466.87 |
| 预付款项 | 1,833,299.74 | 2,940,774.7 | 6,203,224.99 | 10,938,059.6 |
| 其他应收款合计 | 2,754,346.98 | 8,268,462.2 | 5,071,233.24 | 6,691,193.36 |
| 存货 | 201,820,443.93 | 149,244,866.12 | 174,581,808.55 | 142,746,939.12 |
| 一年内到期的非流动资产 | 94,956,917.81 | - | 164,924,125 | 163,624,625 |
| 其他流动资产 | 971,548.85 | 6,816,693.62 | 1,279,185,077.19 | 1,237,245,215.74 |
| 流动资产合计 | 1,687,542,005.22 | 1,396,528,945.74 | 2,163,820,942.01 | 2,270,871,424.14 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | - | 53,087,156.95 |
| 其他权益工具投资 | 42,039,463.57 | 41,997,541.69 | 42,185,898.49 | - |
| 固定资产 | 1,043,465,587.94 | 1,039,721,226.95 | 1,010,310,835.16 | 934,535,089.61 |
| 在建工程 | 135,245,568.7 | 130,402,893.05 | 137,183,881.8 | 147,808,058.95 |
| 无形资产 | 72,622,358.96 | 73,644,504.59 | 74,666,650.22 | 45,219,295.85 |
| 其他非流动资产 | 1,498,503,853.71 | 1,771,656,391.13 | 990,672,303.58 | 1,030,408,560.8 |
| 非流动资产合计 | 2,791,876,832.88 | 3,057,422,557.41 | 2,255,019,569.25 | 2,211,058,162.16 |
| 资产总计 | 4,479,418,838.1 | 4,453,951,503.15 | 4,418,840,511.26 | 4,481,929,586.3 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 119,545,766.23 | 102,096,051.64 | 95,848,037.27 | 86,977,589.75 |
| 其中：应付票据 | 14,691,500 | 13,155,600 | 9,250,500 | 26,319,680 |
| 应付账款 | 104,854,266.23 | 88,940,451.64 | 86,597,537.27 | 60,657,909.75 |
| 合同负债 | 4,232,223.57 | 9,081,921.15 | 11,301,902.09 | 7,651,087.97 |
| 应付职工薪酬 | 5,984,821.78 | 5,706,119.85 | 7,593,429.12 | 6,438,247.75 |
| 应交税费 | 1,512,320.6 | 12,841,708.19 | 1,169,467.15 | 1,640,619.63 |
| 其他应付款合计 | 100,353,718.35 | 844,002 | 275,403.05 | 546,027.5 |
| 应付股利 | 100,000,000 | - | - | - |
| 其他流动负债 | 1,757,755.13 | 1,676,302.68 | 1,797,481.63 | 4,450,396.06 |
| 流动负债合计 | 233,386,605.66 | 132,246,105.51 | 117,985,720.31 | 107,703,968.66 |
| 非流动负债: | | | | |
| 递延收益 | 1,902,621.87 | 2,169,421.88 | 2,436,221.89 | 2,703,021.9 |
| 递延所得税负债 | 54,071,589.33 | 54,477,411.8 | 59,291,346.12 | 56,565,281.63 |
| 非流动负债合计 | 55,974,211.2 | 56,646,833.68 | 61,727,568.01 | 59,268,303.53 |
| 负债合计 | 289,360,816.86 | 188,892,939.19 | 179,713,288.32 | 166,972,272.19 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 202,325,700 | 202,325,700 | 202,325,700 | 202,325,700 |
| 资本公积 | 3,518,157,331.07 | 3,517,499,649.88 | 3,517,499,649.88 | 3,517,499,649.88 |
| 减:库存股 | 60,689,990.76 | 60,689,990.76 | 60,689,990.76 | 60,689,990.76 |
| 其他综合收益 | 33,544.03 | -2,089.56 | 158,013.72 | - |
| 盈余公积 | 97,441,336.1 | 92,385,197.19 | 92,385,197.19 | 89,971,427.2 |
| 未分配利润 | 432,790,100.8 | 513,540,097.21 | 487,448,652.91 | 565,850,527.79 |
| 归属于母公司股东权益合计 | 4,190,058,021.24 | 4,265,058,563.96 | 4,239,127,222.94 | 4,314,957,314.11 |
| 股东权益合计 | 4,190,058,021.24 | 4,265,058,563.96 | 4,239,127,222.94 | 4,314,957,314.11 |
| 负债和股东权益合计 | 4,479,418,838.1 | 4,453,951,503.15 | 4,418,840,511.26 | 4,481,929,586.3 |
| 公告日期 | 2026-08-28 | 2026-04-29 | 2026-04-29 | 2025-10-27 |
| 审计意见(境内) | | | 标准无保留意见 | |